Follow the people · Insider
Vincent S. LoPriore
Vincent S. LoPriore files insider transactions with the SEC as an executive chairman of Hepion Pharmaceuticals (HEPA). We hold 2 disclosed purchases and sales filed since 5 November 2025, 1 of them in the last 90 days.
- Files forHEPA
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 21 April 2026 — 19 August 2026Executive Chairman · Hepion Pharmaceuticals (HEPA)7 Form 4 lines · source: SEC Form 4
- Filed 3 November 2025 — 3 November 2025Executive Chairman · Tharimmune (THAR)1 Form 4 line · source: SEC Form 4
Everything they disclosed
8 entries, newest first — one per disclosure report, one per Form 4 line- was granted 1,345,500 shares of Hepion Pharmaceuticals (a derivative holding)SEC Form 421 August 2026Stock Options · traded 19 August 2026 · filed 21 August 2026
- ▲ bought on the open market 8,000,000 shares of Hepion PharmaceuticalsSEC Form 412 August 2026Common Stock · traded 3 August 2026 · filed 12 August 2026
- ▲ bought on the open market 2,000,000 shares of Hepion PharmaceuticalsSEC Form 412 August 2026Common Stock · traded 3 August 2026 · filed 12 August 2026
- ▲ bought on the open market 8,000,000 shares of Hepion Pharmaceuticals (a derivative holding)SEC Form 412 August 2026Warrants · traded 3 August 2026 · filed 12 August 2026
- ▲ bought on the open market 2,000,000 shares of Hepion Pharmaceuticals (a derivative holding)SEC Form 412 August 2026Warrants · traded 3 August 2026 · filed 12 August 2026
- ▲ bought on the open market 5,000,000 shares of Hepion PharmaceuticalsSEC Form 427 April 2026Common Stock, par value $0.0001 per share · traded 21 April 2026 · filed 27 April 2026
- ▲ bought on the open market 1,250,000 shares of Hepion PharmaceuticalsSEC Form 427 April 2026Common Stock, par value $0.0001 per share · traded 21 April 2026 · filed 27 April 2026
- was granted 90,000 shares of Tharimmune (a derivative holding)SEC Form 45 November 2025Stock Option · traded 3 November 2025 · filed 5 November 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.